Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Rein

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Diabetes Care|May 21, 2010
Roles of the metabolic syndrome, HDL cholesterol, and coronary atherosclerosis in subclinical inflammationPhilipp Rein, Christoph H Saely, Stefan Beer, et al.
Atherosclerosis|March 10, 2015
Is albuminuria a myocardial infarction risk equivalent for atherothrombotic events?Philipp Rein, Christoph H Saely, Alexander Vonbank, et al.
Atherosclerosis|April 3, 2010
Serial decline of kidney function as a novel biomarker for the progression of atherothrombotic diseasePhilipp Rein, Christoph H Saely, Axel Muendlein, et al.
The American Journal of Cardiology|April 5, 2014
Impact of the albumin to creatinine ratio and the coronary artery state on vascular eventsPhilipp Rein, Christoph H Saely, Alexander Vonbank, et al.
European Journal of Preventive Cardiology|April 17, 2012
Eccentric endurance exercise economically improves metabolic and inflammatory risk factorsMarkus Zeppetzauer, Heinz Drexel, Alexander Vonbank, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 16, 2011
Insulin resistance is associated with the metabolic syndrome and is not directly linked to coronary artery diseaseAlexander Vonbank, Christoph H Saely, Philipp Rein, et al.
Atherosclerosis|February 16, 2015
Systemic inflammation is higher in peripheral artery disease than in stable coronary artery diseasePhilipp Rein, Christoph H Saely, Günther Silbernagel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 16, 2008
Type 2 diabetes significantly modulates the cardiovascular risk conferred by the PAI-1 -675 4G/5G polymorphism in angiographied coronary patientsChristoph H Saely, Axel Muendlein, Alexander Vonbank, et al.
Plos One|December 6, 2014
Genome-wide association study reveals a polymorphism in the podocyte receptor RANK for the decline of renal function in coronary patientsAndreas Leiherer, Axel Muendlein, Philipp Rein, et al.
Plos One|November 24, 2011
Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitusCarine Steiner, Alaa Othman, Christoph H Saely, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Diabetes Care|May 21, 2010
Roles of the metabolic syndrome, HDL cholesterol, and coronary atherosclerosis in subclinical inflammationPhilipp Rein, Christoph H Saely, Stefan Beer, et al.
Atherosclerosis|March 10, 2015
Is albuminuria a myocardial infarction risk equivalent for atherothrombotic events?Philipp Rein, Christoph H Saely, Alexander Vonbank, et al.
Atherosclerosis|April 3, 2010
Serial decline of kidney function as a novel biomarker for the progression of atherothrombotic diseasePhilipp Rein, Christoph H Saely, Axel Muendlein, et al.
The American Journal of Cardiology|April 5, 2014
Impact of the albumin to creatinine ratio and the coronary artery state on vascular eventsPhilipp Rein, Christoph H Saely, Alexander Vonbank, et al.
European Journal of Preventive Cardiology|April 17, 2012
Eccentric endurance exercise economically improves metabolic and inflammatory risk factorsMarkus Zeppetzauer, Heinz Drexel, Alexander Vonbank, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 16, 2011
Insulin resistance is associated with the metabolic syndrome and is not directly linked to coronary artery diseaseAlexander Vonbank, Christoph H Saely, Philipp Rein, et al.
Atherosclerosis|February 16, 2015
Systemic inflammation is higher in peripheral artery disease than in stable coronary artery diseasePhilipp Rein, Christoph H Saely, Günther Silbernagel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 16, 2008
Type 2 diabetes significantly modulates the cardiovascular risk conferred by the PAI-1 -675 4G/5G polymorphism in angiographied coronary patientsChristoph H Saely, Axel Muendlein, Alexander Vonbank, et al.
Plos One|December 6, 2014
Genome-wide association study reveals a polymorphism in the podocyte receptor RANK for the decline of renal function in coronary patientsAndreas Leiherer, Axel Muendlein, Philipp Rein, et al.
Plos One|November 24, 2011
Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitusCarine Steiner, Alaa Othman, Christoph H Saely, et al.
Pageof 4